We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+12.56%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$53.7B
AUM Growth
+$4.94B
(+10%)
Cap. Flow
+$233M
Cap. Flow
% of AUM
0.43%
Top 10 Holdings %
Top 10 Hldgs %
26.8%
Holding
1,539
New
66
Increased
528
Reduced
500
Closed
103
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$157M |
| 2 |
Verizon
VZ
|
+$140M |
| 3 |
Apple
AAPL
|
+$117M |
| 4 |
KLA
KLAC
|
+$115M |
| 5 |
Dell
DELL
|
+$94.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XRTX
XORTX Therapeutics
XRTX
|
+$161M |
| 2 |
L3Harris
LHX
|
+$104M |
| 3 |
Voya Financial
VOYA
|
+$99.6M |
| 4 |
BCE
BCE
|
+$88.6M |
| 5 |
NVIDIA
NVDA
|
+$87.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.6% |
| 2 | Healthcare | 16.46% |
| 3 | Financials | 10.3% |
| 4 | Industrials | 9.81% |
| 5 | Consumer Discretionary | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Caribou Biosciences
CRBU
$160M
| $666K | ﹤0.01% |
130,000
| – | – |
|
952
Yelp
YELP
$1.32B
| $661K | ﹤0.01% |
17,080
+13,822
| +424% | +$573K |
|
953
Interactive Brokers
IBKR
$41.4B
| $659K | ﹤0.01% |
24,172
| – | – |
|
954
SITE Centers
SITC
$158M
| $654K | ﹤0.01% |
58,364
| – | – |
|
955
Insight Enterprises
NSIT
$4.6B
| $652K | ﹤0.01% |
3,529
+342
| +11% | +$63.2K |
|
956
COPT Defense Properties
CDP
$4.23B
| $648K | ﹤0.01% |
26,964
| – | – |
|
957
Xerox
XRX
$412M
| $638K | ﹤0.01% |
36,693
+8,496
| +30% | +$149K |
|
958
Syndax Pharmaceuticals
SNDX
$1.7B
| $636K | ﹤0.01% |
28,300
| – | – |
|
959
Crane Co
CR
$12.7B
| $631K | ﹤0.01% |
4,709
-5,237
| -53% | -$645K |
|
960
SiriusXM
SIRI
$9.43B
| $628K | ﹤0.01% |
16,189
+1,143
| +8% | +$54.4K |
|
|
TCN
961
DELISTED
Tricon Residential Inc.
TCN
| $625K | ﹤0.01% |
57,872
| – | – |
|
|
PARA
962
DELISTED
Paramount Global Class B
PARA
| $622K | ﹤0.01% |
53,549
+1,846
| +4% | +$23.2K |
|
|
COOP
963
DELISTED
Mr. Cooper
COOP
| $616K | ﹤0.01% |
7,931
| – | – |
|
964
Huntington Ingalls Industries
HII
$12.8B
| $615K | ﹤0.01% |
2,205
+131
| +6% | +$36.1K |
|
965
LXP Industrial Trust
LXP
$3.58B
| $606K | ﹤0.01% |
13,861
| – | – |
|
966
Alector
ALEC
$228M
| $605K | ﹤0.01% |
100,000
| – | – |
|
967
Power Integrations
POWI
$3.48B
| $605K | ﹤0.01% |
8,622
+633
| +8% | +$47.3K |
|
968
Empire State Realty Trust
ESRT
$836M
| $603K | ﹤0.01% |
63,450
+24,580
| +63% | +$242K |
|
969
Diamondrock Hospitality Co
DRH
$2.51B
| $598K | ﹤0.01% |
63,235
| – | – |
|
970
Ormat Technologies
ORA
$6.98B
| $597K | ﹤0.01% |
9,049
+4,072
| +82% | +$272K |
|
971
Veracyte
VCYT
$3.42B
| $587K | ﹤0.01% |
27,297
| – | – |
|
972
Lantheus
LNTH
$6.59B
| $586K | ﹤0.01% |
9,805
+3,171
| +48% | +$187K |
|
973
Zai Lab
ZLAB
$2.92B
| $586K | ﹤0.01% |
36,648
-30,000
| -45% | -$632K |
|
974
Scholar Rock
SRRK
$6.46B
| $583K | ﹤0.01% |
38,000
| – | – |
|
975
Descartes Systems
DSGX
$6.62B
| $582K | ﹤0.01% |
6,379
-150
| -2% | -$13.2K |
|
Similar funds
NAMI
DekaBank Deutsche Girozentrale's Q1 2024 Portfolio in Review
As of Q1 2024, DekaBank Deutsche Girozentrale held 1,539 positions worth $53.7B, up 10% from $48.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
DekaBank Deutsche Girozentrale's Q1 2024 filing shows 66 new, 528 increased, 500 reduced and 103 closed positions. Its largest new stake was Flutter Entertainment: 112,763 shares worth $22.5M. The largest sale was XORTX Therapeutics, an estimated $161M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.
- DekaBank Deutsche Girozentrale's largest Q1 2024 buy was Flutter Entertainment: 112,763 shares worth $22.5M.
- DekaBank Deutsche Girozentrale added most to Alphabet (Google) Class A in Q1 2024, an estimated $157M increase.
- DekaBank Deutsche Girozentrale's biggest Q1 2024 reduction was Voya Financial, cutting an estimated $99.6M.
- DekaBank Deutsche Girozentrale fully exited XORTX Therapeutics in Q1 2024, selling an estimated $161M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 27% of its $53.7B portfolio in Q1 2024.
- DekaBank Deutsche Girozentrale opened 66 new positions and closed 103 in Q1 2024.
- DekaBank Deutsche Girozentrale's portfolio value rose 10% quarter-over-quarter to $53.7B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2024, filed 24 Apr 2024.